Dexamethasone Reduces Mortality in COVID-19: The RECOVERY Trial
About this episode
Today we're back with a spirited discussion of a pre-print publication for the dexamethasone arm of the RECOVERY trial. Should hospitalized COVID19 patients receive dexamethasone? Take a listen and decide for yourself.
Dexamethasone in Hospitalized Patients with COVID-19
Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R
Get every episode summarized
Each time Last Week in Medicine publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Last Week in Medicine
Catheter Directed Fibrinolysis for Acute PE (HI-PEITHO), NEWS2 Plus Procalcitoni...
Last Week in Medicine
Bleeding Risk with Apixaban vs Rivaroxaban for Acute VTE (COBRRA), Left Atrial A...
Last Week in Medicine
2026 ACC/AHA Guidelines for Acute Pulmonary Embolism
Last Week in Medicine
Hematopoietic Stem Cell Gene Therapy for Cystinosis
Last Week in Medicine